TPCN2 and melanoma: Lately, we identified GTPase Rab7 as an enhancer of TPC2 channel activity in melanoma, providing first-line evidence for a Rab7/TPC2/Wnt signalling axis that drives tumour growth, migration, and dissemination (12).